GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.
Cancer-associated fibroblasts (CAFs) play important roles in cancer progression through their complex interactions with cancer cells. The secreted bone morphogenetic protein antagonist, gremlin1 (GREM1) is expressed by the CAFs of basal cell carcinomas (BCCs), and promotes the growth of cancer cells...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC5367809?pdf=render |
| _version_ | 1830486428294840320 |
|---|---|
| author | Hye Sung Kim Myung Soo Shin Min Seok Cheon Jae Wang Kim Cheol Lee Woo Ho Kim Young Sill Kim Bo Gun Jang |
| author_facet | Hye Sung Kim Myung Soo Shin Min Seok Cheon Jae Wang Kim Cheol Lee Woo Ho Kim Young Sill Kim Bo Gun Jang |
| author_sort | Hye Sung Kim |
| collection | DOAJ |
| description | Cancer-associated fibroblasts (CAFs) play important roles in cancer progression through their complex interactions with cancer cells. The secreted bone morphogenetic protein antagonist, gremlin1 (GREM1) is expressed by the CAFs of basal cell carcinomas (BCCs), and promotes the growth of cancer cells. In this study, we investigated the expression of GREM1 mRNAs in various benign and malignant skin tumors, including various BCC subtypes. Analysis by RNA in situ hybridization (ISH) revealed that fibroblasts in the scar tissue expressed GREM1 and α-smooth muscle actin (α-SMA), whereas resident fibroblasts in the dermis of the normal skin did not express GREM1. Real-time polymerase chain reaction analysis showed significantly higher GREM1 expression in skin cancers and pilomatricomas (PMCs) than in other benign skin tumors. Tissue microarrays analyzed by RNA ISH for GREM1 expression also demonstrated that 23% of BCCs, 42% of squamous cell carcinomas, 20% of melanomas, and 90% of PMCs were positive for GREM1 expression, whereas trichoepitheliomas, eccrine poromas, hidradenomas, and spiradenomas were negative for GREM1 expression. Most BCCs that were GREM1 expression positive were of desmoplastic or mixed subtypes, and GREM1 expression was localized to activated myofibroblasts at the tumoral-stromal interface. Interestingly, most PMCs harbored GREM1-expressing fibroblasts, probably because of the inflammatory responses caused by foreign body reactions to keratin. Additionally, in BCCs, stromal GREM1 expression had a strong correlation with CD10 expression. In conclusion, GREM1 is frequently expressed by myofibroblasts in scars or in the stroma of basal cell carcinomas, suggesting that GREM1 expression can be a marker for activated myofibroblasts in the cancer stroma or in scar tissue. |
| first_indexed | 2024-12-21T18:42:56Z |
| format | Article |
| id | doaj.art-3ae8fcb61e0a44b7b56f5cabb3b44f41 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T18:42:56Z |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-3ae8fcb61e0a44b7b56f5cabb3b44f412022-12-21T18:53:58ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01123e017456510.1371/journal.pone.0174565GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas.Hye Sung KimMyung Soo ShinMin Seok CheonJae Wang KimCheol LeeWoo Ho KimYoung Sill KimBo Gun JangCancer-associated fibroblasts (CAFs) play important roles in cancer progression through their complex interactions with cancer cells. The secreted bone morphogenetic protein antagonist, gremlin1 (GREM1) is expressed by the CAFs of basal cell carcinomas (BCCs), and promotes the growth of cancer cells. In this study, we investigated the expression of GREM1 mRNAs in various benign and malignant skin tumors, including various BCC subtypes. Analysis by RNA in situ hybridization (ISH) revealed that fibroblasts in the scar tissue expressed GREM1 and α-smooth muscle actin (α-SMA), whereas resident fibroblasts in the dermis of the normal skin did not express GREM1. Real-time polymerase chain reaction analysis showed significantly higher GREM1 expression in skin cancers and pilomatricomas (PMCs) than in other benign skin tumors. Tissue microarrays analyzed by RNA ISH for GREM1 expression also demonstrated that 23% of BCCs, 42% of squamous cell carcinomas, 20% of melanomas, and 90% of PMCs were positive for GREM1 expression, whereas trichoepitheliomas, eccrine poromas, hidradenomas, and spiradenomas were negative for GREM1 expression. Most BCCs that were GREM1 expression positive were of desmoplastic or mixed subtypes, and GREM1 expression was localized to activated myofibroblasts at the tumoral-stromal interface. Interestingly, most PMCs harbored GREM1-expressing fibroblasts, probably because of the inflammatory responses caused by foreign body reactions to keratin. Additionally, in BCCs, stromal GREM1 expression had a strong correlation with CD10 expression. In conclusion, GREM1 is frequently expressed by myofibroblasts in scars or in the stroma of basal cell carcinomas, suggesting that GREM1 expression can be a marker for activated myofibroblasts in the cancer stroma or in scar tissue.http://europepmc.org/articles/PMC5367809?pdf=render |
| spellingShingle | Hye Sung Kim Myung Soo Shin Min Seok Cheon Jae Wang Kim Cheol Lee Woo Ho Kim Young Sill Kim Bo Gun Jang GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas. PLoS ONE |
| title | GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas. |
| title_full | GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas. |
| title_fullStr | GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas. |
| title_full_unstemmed | GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas. |
| title_short | GREM1 is expressed in the cancer-associated myofibroblasts of basal cell carcinomas. |
| title_sort | grem1 is expressed in the cancer associated myofibroblasts of basal cell carcinomas |
| url | http://europepmc.org/articles/PMC5367809?pdf=render |
| work_keys_str_mv | AT hyesungkim grem1isexpressedinthecancerassociatedmyofibroblastsofbasalcellcarcinomas AT myungsooshin grem1isexpressedinthecancerassociatedmyofibroblastsofbasalcellcarcinomas AT minseokcheon grem1isexpressedinthecancerassociatedmyofibroblastsofbasalcellcarcinomas AT jaewangkim grem1isexpressedinthecancerassociatedmyofibroblastsofbasalcellcarcinomas AT cheollee grem1isexpressedinthecancerassociatedmyofibroblastsofbasalcellcarcinomas AT woohokim grem1isexpressedinthecancerassociatedmyofibroblastsofbasalcellcarcinomas AT youngsillkim grem1isexpressedinthecancerassociatedmyofibroblastsofbasalcellcarcinomas AT bogunjang grem1isexpressedinthecancerassociatedmyofibroblastsofbasalcellcarcinomas |